Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics
Open Access
- 27 November 2021
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Computational and Structural Biotechnology Journal
- Vol. 19, 6490-6504
Abstract
The adenosine-triphosphate-(ATP)-binding cassette (ABC) transporter ABCA7 is a genetic risk factor for Alzheimer’s disease (AD). Defective ABCA7 promotes AD development and/or progression. Unfortunately, ABCA7 belongs to the group of ‘under-studied’ ABC transporters that cannot be addressed by small-molecules. However, such small-molecules would allow for the exploration of ABCA7 as pharmacological target for the development of new AD diagnostics and therapeutics. Pan-ABC transporter modulators inherit the potential to explore under-studied ABC transporters as novel pharmacological targets by potentially binding to the proposed ‘multitarget binding site’. Using the recently reported cryogenic-electron microscopy (cryo-EM) structures of ABCA1 and ABCA4, a homology model of ABCA7 has been generated. A set of novel, diverse, and potent pan-ABC transporter inhibitors has been docked to this ABCA7 homology model for the discovery of the multitarget binding site. Subsequently, application of pharmacophore modelling identified the essential pharmacophore features of these compounds that may support the rational drug design of innovative diagnostics and therapeutics against AD.Keywords
Funding Information
- Nasjonalforeningen for Folkehelsen
- Helse Sør-Øst RHF
- Latvijas Zinātnes Padome
- Norges Forskningsråd
- Deutsche Forschungsgemeinschaft
This publication has 155 references indexed in Scilit:
- Structures of ABCB10, a human ATP-binding cassette transporter in apo- and nucleotide-bound statesProceedings of the National Academy of Sciences, 2013
- Localization of putative binding sites for cyclic guanosine monophosphate and the anti-cancer drug 5-fluoro-2′-deoxyuridine-5′-monophosphate on ABCC11 in silico modelsBMC Structural Biology, 2013
- The Human Transporter Associated with Antigen ProcessingJournal of Biological Chemistry, 2012
- Cerebral amyloid-β proteostasis is regulated by the membrane transport protein ABCC1 in miceJournal of Clinical Investigation, 2011
- HMG-CoA reductase inhibitors enhance phagocytosis by upregulating ATP-binding cassette transporter A7Atherosclerosis, 2011
- Direct binding of cholesterol to the amyloid precursor protein: An important interaction in lipid–Alzheimer's disease relationships?Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Effect of hypouricaemic and hyperuricaemic drugs on the renal urate efflux transporter, multidrug resistance protein 4British Journal of Pharmacology, 2008
- UniProt: the Universal Protein knowledgebaseNucleic Acids Research, 2004
- The Protein Data BankNucleic Acids Research, 2000